Published in Mucosal Immunol on April 10, 2013
Defensins: antifungal lessons from eukaryotes. Front Microbiol (2014) 0.99
Physiologic hypoxia and oxygen homeostasis in the healthy intestine. A Review in the Theme: Cellular Responses to Hypoxia. Am J Physiol Cell Physiol (2015) 0.96
Reduction of human defensin 5 affords a high-affinity zinc-chelating peptide. ACS Chem Biol (2013) 0.91
Oxygen metabolism and barrier regulation in the intestinal mucosa. J Clin Invest (2016) 0.81
Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide. Mucosal Immunol (2014) 0.81
P2X7 receptor activation regulates rapid unconventional export of transglutaminase-2. J Cell Sci (2015) 0.80
Reduction Impairs the Antibacterial Activity but Benefits the LPS Neutralization Ability of Human Enteric Defensin 5. Sci Rep (2016) 0.78
Defensins and sepsis. Biomed Res Int (2014) 0.76
Salivary Antimicrobial Peptides in Early Detection of Periodontitis. Front Cell Infect Microbiol (2015) 0.76
Analysis of the link between the redox state and enzymatic activity of the HtrA (DegP) protein from Escherichia coli. PLoS One (2015) 0.75
Antimicrobial activity of high-mobility-group box 2: a new function to a well-known protein. Antimicrob Agents Chemother (2013) 0.75
Thiol-Disulfide Exchange Reactions in the Mammalian Extracellular Environment. Annu Rev Chem Biomol Eng (2016) 0.75
Ubiquitously expressed Human Beta Defensin 1 (hBD1) forms bacteria-entrapping nets in a redox dependent mode of action. PLoS Pathog (2017) 0.75
Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem (2000) 7.25
Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell (1997) 5.99
The indigenous gastrointestinal microflora. Trends Microbiol (1996) 4.51
Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U S A (1998) 3.85
Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett (1996) 3.39
Disulfide bonds as switches for protein function. Trends Biochem Sci (2003) 3.14
MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature (2002) 3.10
Proteins of the PDI family: unpredicted non-ER locations and functions. J Cell Physiol (2002) 2.75
Human beta-defensins. Cell Mol Life Sci (2006) 2.57
Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J Cell Sci (1994) 2.39
Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci U S A (2002) 2.35
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature (2011) 2.31
Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat Immunol (2002) 2.28
Glutathiolation regulates tumor necrosis factor-alpha-induced caspase-3 cleavage and apoptosis: key role for glutaredoxin in the death pathway. Circ Res (2006) 2.24
Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem (1992) 2.09
Human airway epithelia express a beta-defensin. Am J Respir Cell Mol Biol (1997) 2.07
Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem (1999) 1.99
Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death. Blood (2008) 1.96
Role of glutaredoxin in metabolic oxidative stress. Glutaredoxin as a sensor of oxidative stress mediated by H2O2. J Biol Chem (2002) 1.82
The thioredoxin system--from science to clinic. Med Res Rev (2004) 1.82
Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res (1999) 1.57
Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J Mol Biol (1998) 1.56
Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J Biol Chem (2002) 1.54
Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum (1999) 1.29
Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis. Gastroenterology (2011) 1.26
Antimicrobial peptides in the first line defence of human colon mucosa. Peptides (2003) 1.24
Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease. Scand J Gastroenterol (2008) 1.22
Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease. Respir Res (2006) 1.22
Cellular and plasma levels of human glutaredoxin 1 and 2 detected by sensitive ELISA systems. Biochem Biophys Res Commun (2004) 1.20
Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity. Antimicrob Agents Chemother (2010) 1.14
Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress. Blood (2010) 1.14
Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidation. Biochem Biophys Res Commun (2008) 1.13
Novel anti-bacterial activities of β-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog (2011) 1.11
Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gastroenterology (2006) 1.11
Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc Natl Acad Sci U S A (2001) 1.11
Control of von Willebrand factor multimer size by thrombospondin-1. J Exp Med (2001) 1.10
Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose. J Biol Chem (2012) 1.06
Activation of extracellular transglutaminase 2 by thioredoxin. J Biol Chem (2011) 1.03
Human antimicrobial proteins effectors of innate immunity. J Endotoxin Res (2007) 1.02
Human beta-defensin 1: a restless warrior against allergies, infections and cancer. Int J Biochem Cell Biol (2010) 1.00
Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91. J Leukoc Biol (2009) 1.00
A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. Nucleic Acids Res (1996) 0.94
Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin. J Biol Chem (2010) 0.92
Detection of membrane associated thioredoxin on human cell lines. Biochem Biophys Res Commun (1997) 0.89
High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells. Cancer Res (1995) 0.88
Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinase. Antioxid Redox Signal (2000) 0.87
Regulation of interleukin-4 signaling by extracellular reduction of intramolecular disulfides. Biochem Biophys Res Commun (2009) 0.83
Flow cytometric measurement of intracellular migration inhibition factor and tumour necrosis factor alpha in the mucosa of patients with coeliac disease. Clin Exp Immunol (2001) 0.79
The oral gold compound auranofin triggers arachidonate release and cyclooxygenase metabolism in the alveolar macrophage. Prostaglandins (1988) 0.77
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis (2010) 6.75
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut (2004) 4.39
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis (2009) 3.22
Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients. Aliment Pharmacol Ther (2012) 2.87
Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol (2000) 2.66
European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis (2008) 2.14
Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus. Aliment Pharmacol Ther (2010) 2.12
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis (2008) 1.99
Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol (2002) 1.83
Synergistic sedation with low-dose midazolam and propofol for colonoscopies. Endoscopy (2000) 1.64
Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol (2008) 1.57
Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI. Hepatology (2001) 1.54
[Endogenous prostaglandin synthesis and gastritis: lack of correlation with endoscopic findings, Helicobacter colonization and leukocytic infiltration of the mucosa]. Z Gastroenterol (1992) 1.41
Safety and efficacy of repeated shockwave lithotripsy of gallstones with and without adjuvant bile acid therapy. Gastroenterology (1997) 1.41
Feedback regulation of bile acid synthesis measured by stable isotope kinetics in humans. Eur J Gastroenterol Hepatol (1996) 1.39
[Treatment of Crohn's disease: step-up or top-down?]. Dtsch Med Wochenschr (2010) 1.37
Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease. Mucosal Immunol (2008) 1.34
Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism. J Lipid Res (1985) 1.34
Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins. Dig Dis Sci (2002) 1.26
Innate immune dysfunction in inflammatory bowel disease. J Intern Med (2012) 1.25
Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism. J Biol Chem (2001) 1.24
[Clinical practice guideline on diagnosis and treatment of Crohn's disease]. Z Gastroenterol (2008) 1.19
Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Intern Med (2005) 1.15
The quality of gastroenterological reports based on free text dictation: an evaluation in endoscopy and ultrasonography. Endoscopy (1991) 1.14
Decreased Paneth cell defensin expression in ileal Crohn's disease is independent of inflammation, but linked to the NOD2 1007fs genotype. Gut (2009) 1.11
Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol (2008) 1.09
Defensins -- innate immunity at the epithelial frontier. Eur J Gastroenterol Hepatol (2001) 1.06
Bile acids regulate hepatic low density lipoprotein receptor activity in the hamster by altering cholesterol flux across the liver. Proc Natl Acad Sci U S A (1986) 1.05
Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). Am J Gastroenterol (1998) 1.04
Enhanced intestinal expression of heat shock protein 70 in patients with inflammatory bowel diseases. Dig Dis Sci (1999) 1.04
Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol (1999) 1.02
Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. J Clin Pathol (2003) 1.01
Elevated serum thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel disease. J Interferon Cytokine Res (1999) 1.00
Cholesterol synthesis and low density lipoprotein uptake are regulated independently in rat small intestinal epithelium. Proc Natl Acad Sci U S A (1983) 0.99
[Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease]. Z Gastroenterol (2004) 0.97
The postprandial portal flow is related to the severity of portal hypertension and liver cirrhosis. J Hepatol (1998) 0.96
Long-term haemodynamic effects of octreotide on postprandial splanchnic hyperemia in humans: a placebo-controlled echo-doppler study. Aliment Pharmacol Ther (1999) 0.96
Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use. Aliment Pharmacol Ther (2001) 0.96
Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha in inflammatory bowel disease. Eur Cytokine Netw (1995) 0.94
A novel role for constitutively expressed epithelial-derived chemokines as antibacterial peptides in the intestinal mucosa. Mucosal Immunol (2009) 0.94
Emergency endoscopic sclerotherapy for bleeding esophageal varices: a prospective study in patients not responding to balloon tamponade. Gastrointest Endosc (1983) 0.93
Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy. Hepatology (1987) 0.93
Absolute rates of cholesterol synthesis in rat intestine in vitro and in vivo: a comparison of different substrates in slices and isolated cells. J Lipid Res (1983) 0.91
Treatment of infected pancreatic pseudocysts by endoscopic ultrasonography-guided cystogastrostomy. Endoscopy (2000) 0.90
Upper gastrointestinal hemorrhage from downhill esophageal varices. Dig Dis Sci (1982) 0.90
Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study. Gut (1999) 0.89
The pancreas and inflammatory bowel diseases. Int J Pancreatol (2000) 0.88
Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease. Aliment Pharmacol Ther (2000) 0.88
ABCB1 single-nucleotide polymorphisms determine tacrolimus response in patients with ulcerative colitis. Clin Pharmacol Ther (2011) 0.88
Age-related decreases in tissue sterol acquisition are mediated by changes in cholesterol synthesis and not low density lipoprotein uptake in the rat. J Lipid Res (1984) 0.88
Quantitative importance of different organs for cholesterol synthesis and low-density-lipoprotein degradation. Biochem Soc Trans (1983) 0.86
[Evidence-based medicine: context and relevance]. Z Gastroenterol (1999) 0.86
[Histoplasmosis: uncommon opportunistic infection in a patient with HIV infection]. Dtsch Med Wochenschr (2012) 0.85
48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study. Dig Dis Sci (2000) 0.85
Influence of cholesterol supply on cell growth and differentiation in cultured enterocytes (CaCo-2). Digestion (1995) 0.84
Newly synthesized cholesterol in human bile and plasma: quantitation by mass isotopomer distribution analysis. Am J Physiol (1997) 0.84
Esophageal varices: current therapy in 1989. Endoscopy (1989) 0.84
Alimentary tract and pancreas. Stimulation of mucosal prostaglandin synthesis in human stomach and duodenum by antacid treatment. Gut (1989) 0.84
The pravastatin-induced decrease of biliary cholesterol secretion is not directly related to an inhibition of cholesterol synthesis in humans. Hepatology (1999) 0.84
Efficacy of double-balloon enteroscopy in the evaluation and treatment of bleeding and non-bleeding small bowel disease. Z Gastroenterol (2007) 0.83
Cyclosporine for induction of remission in Crohn's disease. Cochrane Database Syst Rev (2005) 0.83
Lipoprotein regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cultured intestinal mucosa. Biochim Biophys Acta (1980) 0.83
Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn's disease. Aliment Pharmacol Ther (2009) 0.83
Compartmentalization of cholesterol in hepatic and intestinal cells: implications for bile and lipoprotein secretion. Biochem Soc Trans (1987) 0.83
In vivo modulation of rat liver acyl-coenzyme A:cholesterol acyltransferase by phosphorylation and substrate supply. FEBS Lett (1983) 0.82
Prostaglandin biosynthesis in gastroduodenal mucosa: methodological difficulties and their implications. Scand J Gastroenterol Suppl (1986) 0.82
Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options. Thromb Haemost (2013) 0.82
Two cases of fatal Pneumocystis jirovecii pneumonia as a complication of tacrolimus therapy in ulcerative colitis--a need for prophylaxis. J Crohns Colitis (2010) 0.82
6-thioguanine--efficacy and safety in chronic active Crohn's disease. Aliment Pharmacol Ther (2003) 0.82
HDL3-retroendocytosis in cultured small intestinal crypt cells: a novel mechanism of cholesterol efflux. Biochim Biophys Acta (1991) 0.82
Clathrin-mediated endocytosis of high density lipoprotein3 in human intestinal Caco-2 cells. A post-embedding immunocytochemical study. Biochim Biophys Acta (1997) 0.81
Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study. J Crohns Colitis (2012) 0.81
Modulation of arachidonic acid metabolism by olsalazine and other aminosalicylates in leukocytes. Scand J Gastroenterol (1991) 0.81
Intestinal expression of human heat shock protein 90 in patients with Crohn's disease and ulcerative colitis. Dig Dis Sci (1998) 0.81
Defensin-immunology in inflammatory bowel disease. Gastroenterol Clin Biol (2009) 0.81
Effect of pentagastrin, secretin and cholecystokinin on growth and differentiation in organ cultured rabbit small intestine. Horm Metab Res (1986) 0.81
Remission maintenance by tioguanine in chronic active Crohn's disease. Aliment Pharmacol Ther (2003) 0.81
Compartmentalization of cholesterol metabolism and cellular growth in cultured intestinal crypt cells. Biochim Biophys Acta (1991) 0.81
Enhanced human beta-defensin-2 (hBD-2) expression by corticosteroids is independent of NF-kappaB in colonic epithelial cells (CaCo2). Dig Dis Sci (2005) 0.81
Bile acid synthesis from newly synthesized vs. preformed cholesterol precursor pools in the rat. Hepatology (1993) 0.81
Crohn's disease and sarcoidosis: systemic granulomatosis? Eur J Gastroenterol Hepatol (1997) 0.81
Treatment of unresectable carcinoma of the esophagus or the gastroesophageal junction by mesh stents with or without radiochemotherapy. Int J Oncol (1998) 0.80
Dual modulation of hepatic and intestinal acyl-CoA: cholesterol acyltransferase activity by (de-)phosphorylation and substrate supply in vitro. FEBS Lett (1983) 0.80
Limited heat-shock protein 72 induction in Caco-2 cells by L-glutamine. Digestion (2001) 0.80
Synthesis and coenzyme A-dependent esterification of cholesterol in rat intestinal epithelium. Differences in cellular localization and mechanisms of regulation. J Biol Chem (1983) 0.80
Mesenteric blood flow is related to disease activity and risk of relapse in Crohn's disease: a prospective follow-up study. Am J Gastroenterol (1999) 0.80
Biliary cholesterol secretion and bile acid formation in the hamster: the role of newly synthesized cholesterol. J Lipid Res (1994) 0.80
Biliary lipids, cholesterol and bile synthesis: different adaptive mechanisms to dietary cholesterol in lean and obese subjects. Aliment Pharmacol Ther (2006) 0.80
3-Hydroxy-3-methylglutaryl CoA reductase in cultured hepatocytes. Regulation by heterologous lipoproteins and hormones. Atherosclerosis (1982) 0.80
Prostaglandin synthesis along the gastrointestinal tract of the rabbit: differences in total synthesis and profile. Prostaglandins (1987) 0.80
Chronic hepatitis C, common variable immunodeficiency and autoimmune hemolytic anemia. Coincidence by chance or common etiology? Hepatogastroenterology (2001) 0.79